Table 1. Clinical applications of ambient ionization mass spectrometry (AIMS).
| Technique | Year | Type of sample | Application | Molecular Speciesa | Reference |
|---|---|---|---|---|---|
| DESI | 2009 | Human serum, rat brain section | Hydroxyl-containing molecules detection | Cholesterol, glucose, fructose, phospholipids | 10 |
| 2010 | Human blood | Therapeutic drug monitoring | Sitamaquine, prazosin, terfenadine, verapamil | 18 | |
| 2012 | Brain tissue section | Brain cancer diagnosis | PS, PI, FA | 24 | |
| 2014 | Breast tissue section | Breast cancer diagnosis | FA, PI, PS, PE | 21 | |
| 2014 | Brain tissue section | Brain cancer diagnosis | 2-Hydroxyglutarate | 33 | |
| 2015 | Prostate tissue section | Prostate cancer diagnosis | PE, PS, PC, PI | 22b | |
| LMJ-SSP | 2008 | Rat tissue | Drug and metabolites detection | Reserpine, glutathione, sulforaphane | 27 |
| 2013 | Sheep blood | Protein identification, drug detection | Hemoglobin, hydroxypropranolol, hydrochloride | 29 | |
| NanoDESI | 2013 | Mouse tissue section | Proteins and peptides identification | Hemoglobin, ubiquitin, PC, glutathione, | 30, 31 |
| 2016 | Skin tissue | Psoriasis diagnosis | Choline, glutamic acid, canic acid, citrulline | 32 | |
| DART | 2013 | Human serum | Metabolic fingerprinting screening | Not assigned | 35 |
| 2015 | Human plasma | Metabolite quantification | Tyrosine | 36 | |
| REIMS | 2010 | Human tissue | Tissue types identification | Phospholipids | 44 |
| 2013 | Human tissue | Tissue types identification | PA, PE, PI | 41 | |
| 2015 | Human tissue, bacterial growth media | Tissue and bacteria identification | PA, PG, PI, PE, PQS | 43 | |
| 2015 | Porcine tissue, human tissue | Tissue (polyp) identification | TG, PI, PE | 45 | |
| Touch spray ionization | 2014 | Human blood, human prostate, mouse brain | Therapeutic drug monitoring, cancer diagnosis | MDMA, methamphetamine, cocaine, PC, PS, PI, FA | 55 |
| 2014 | Throat swab | Strep throat-related bacterium identification | PG | 56 | |
| 2015 | Prostate tissue | Prostate cancer diagnosis | PE, PS, PC, PI | 22b | |
| Probe-ESI | 2013 | Rat liver | Cancer diagnosis (hepatocellular carcinoma) | PC, TAG | 58 |
| 2013 | Human urine, oral fluid, plasma | Illicit drug monitoring | Methamphetamine, morphine, cocaine, codeine | 57 | |
| 2011 | Human kidney, porcine kidney, stomach | Kidney cancer diagnosis | PI, PE, PS | 59 | |
| Paper spray ionization | 2010 | Human blood, urine | Therapeutic drug monitoring | Imatinib, heroine, atenolol | 66 |
| 2011 | Human blood | Therapeutic drug monitoring | Propranolol, atenolol | 76 | |
| 2012 | Human blood, serum | Newborn screening | Acylcarnitines | 67 | |
| 2011–2016 | Bovine whole blood, rat blood, human blood | Therapeutic drug monitoring, protein identificationc | Amitriptyline, cotinine, methamphetamine, citalopram, hemoglobinc | 69, 72c, 77, 82, 97 | |
| Extractive-ESI | 2007 | Human skin | Metabolites detection | Nicotine, caffeine | 87 |
| 2013 | Human breath | Metabolites detection | Acetonitrile | 88 | |
| Laser ablation-ESI | 2016 | Bacterial colonies | Bacterial colonies identification | PE, PG, lipids, bacterial metabolites | 91 |
| Thermal desorption-ESI | 2016 | Human oral fluid | Pesticides identification | Paraquat, methamidophos, dimethoate, chlorpyrifos, methomyl, triphenyl, phosphate | 92 |
| 2016 | Gastric lavage content | Medications identification | Acetaminophen, diphenhydramine, propranolol, doxepin | 94 |
a Abbreviations in this column: PS, glycerophosphoserines; PI, glycerophosphoinositols; FA, fatty acids; PC, glycerophosphotidylcholines; PE, glycerophosphoethanolamines; PA, phosphatidic acids; PQS, Pseudomonas quorum signal, e.g., 2-heptyl-3-hydroxy-4(1H)-quinolone; PG, phosphatidylglycerols; TG, triglyceride; TAG, triacylglycerol; MDMA, 3,4-methylenedioxymethamphetamine. b TSI- and DESI-MS experiments were both conducted in ref. 22. c Protein identification of hemoglobin was only reported in ref. 72.